IL6 and inflammatory bowel disease: Additionally, chronic systemic inflammation inherent to IBD pathophysiology exacerbates insulin resistance through the action of proinflammatory cytokines (particularly TNF-α, IL-1, and IL-6) which disrupt the insulin signaling cascade [137].